You must log in to view this page.

Nurix Therapeutics Inc. – Filings and Transcripts

NASDAQ: NRIX
Share price (5/22/26): $17.50
Market cap (5/22/26): $1.810 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 02/28/26 Q1

ended 11/30/25 FY 2025

ended 08/31/25 Q3

ended 05/31/25 Q2

ended 02/28/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Registration of securities for employees

Ownership Filter

Saltzman Edward C

News Filter

Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Other Events, Financial Statements or Exhibits

Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update

Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC